Low von Willebrand factor: sometimes a risk factor and sometimes a disease. (1/12)

Functional characterization of a 13-bp deletion (c.-1522_-1510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand disease. (2/12)

Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD. (3/12)

An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease. (4/12)

Clinical measurement of von Willebrand factor by fluorescence correlation spectroscopy. (5/12)

Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients. (6/12)

Establishment and characterization of a new and stable collagen-binding assay for the assessment of von Willebrand factor activity. (7/12)

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease. (8/12)

• 1
• 2